{"id":"W4389627613","doi":"10.1080/13696998.2023.2293379","title":"Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom","year":2023,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Cegep de Saint Jerome; Université de Montréal","funders":"Canadian Institutes of Health Research; Sanofi Genzyme; Novartis Pharma; Multiple Sclerosis International Federation; Sanofi; World Health Organization; Bayer HealthCare; Università di Catania; Multiple Sclerosis Society of Canada; Biogen; Celgene; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; Atara Biotherapeutics; Eisai; Bristol-Myers Squibb","keywords":"Fingolimod; Medicine; Natalizumab; Relapsing remitting; Multiple sclerosis; Cost effectiveness; Physical therapy; Intensive care medicine; Internal medicine; Immunology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009120599,0.0001675086,0.0009198403,0.0006595019,0.00008548269,0.00003508614,0.000214156,0.0001567966,0.000008388155],"category_scores_gemma":[0.00725156,0.0001206165,0.00008381814,0.0005889584,0.0003620746,0.000180571,0.0002086542,0.0008489714,7.843956e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002598396,"about_ca_system_score_gemma":0.0002251076,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004713383,"about_ca_topic_score_gemma":0.0002013507,"domain_scores_codex":[0.9973646,0.0009390205,0.0007197378,0.0002192524,0.0004527433,0.0003046815],"domain_scores_gemma":[0.9885061,0.01068128,0.000323299,0.0001415139,0.0001717405,0.0001760296],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003868776,0.0005196948,0.9524513,0.002219823,0.0005496183,0.0001942099,0.008564577,0.00390457,0.005010687,0.0003009599,0.000203768,0.02221199],"study_design_scores_gemma":[0.01046542,0.0003005817,0.9318912,0.005188604,0.00003062857,0.0001486615,0.00238829,0.04883515,0.0004709327,0.00008896449,0.00008632903,0.000105259],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978246,0.0005438883,0.00007061755,0.0007402762,0.0001099058,0.0006459085,0.000009290303,0.000007115977,0.00004839546],"genre_scores_gemma":[0.9971964,0.002479883,0.0001440825,0.00006477827,0.00006859579,0.00002492463,0.000005595496,0.00001494351,7.872466e-7],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04493058,"threshold_uncertainty_score":0.8681319,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1420528960193775,"score_gpt":0.3668817237976787,"score_spread":0.2248288277783012,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}